Xylo Technologies Financials
| XYLO Stock | 3.19 0.05 1.59% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.41 | 0.3909 |
|
| |||||
| Current Ratio | 1.03 | 1.0821 |
|
|
Investors should never underestimate Xylo Technologies' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Xylo Technologies' cash flow, debt, and profitability to make informed and accurate decisions about investing in Xylo Technologies.
Net Income |
|
Xylo | Select Account or Indicator |
Understanding current and past Xylo Technologies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Xylo Technologies' financial statements are interrelated, with each one affecting the others. For example, an increase in Xylo Technologies' assets may result in an increase in income on the income statement.
Xylo Technologies Stock Summary
Xylo Technologies competes with Albertsons Companies, Northstar Clean, Natural Alternatives, Alvotech, and Cumberland Pharmaceuticals. Xylo Technologies is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 58471G300 58471G409 58471G102 58471G201 58471G508 |
| Older Symbol | MDGS |
| Location | Israel |
| Business Address | 10 Hanechoshet, Tel |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.medigus.com |
Xylo Technologies Key Financial Ratios
| Return On Equity | -0.5 | ||||
| Profit Margin | (0.17) % | ||||
| Operating Margin | (0.16) % | ||||
| Price To Sales | 0.03 X | ||||
| Revenue | 91.72 M |
Xylo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xylo Technologies's current stock value. Our valuation model uses many indicators to compare Xylo Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xylo Technologies competition to find correlations between indicators driving Xylo Technologies's intrinsic value. More Info.Xylo Technologies is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Xylo Technologies' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xylo Technologies' earnings, one of the primary drivers of an investment's value.Xylo Technologies Systematic Risk
Xylo Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Xylo Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Xylo Technologies correlated with the market. If Beta is less than 0 Xylo Technologies generally moves in the opposite direction as compared to the market. If Xylo Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Xylo Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Xylo Technologies is generally in the same direction as the market. If Beta > 1 Xylo Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Xylo Technologies Thematic Clasifications
Xylo Technologies is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Medical Equipment | View |
Today, most investors in Xylo Technologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Xylo Technologies' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Xylo Technologies growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Xylo Technologies November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Xylo Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Xylo Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Xylo Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Xylo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Xylo Technologies's daily price indicators and compare them against related drivers.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 25.69 | |||
| Value At Risk | (8.75) | |||
| Potential Upside | 9.04 |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylo Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Xylo Stock, please use our How to Invest in Xylo Technologies guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylo Technologies. If investors know Xylo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylo Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (25.20) | Revenue Per Share 145.064 | Quarterly Revenue Growth (0.33) | Return On Assets (0.08) | Return On Equity (0.50) |
The market value of Xylo Technologies is measured differently than its book value, which is the value of Xylo that is recorded on the company's balance sheet. Investors also form their own opinion of Xylo Technologies' value that differs from its market value or its book value, called intrinsic value, which is Xylo Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylo Technologies' market value can be influenced by many factors that don't directly affect Xylo Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylo Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylo Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylo Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.